Latest Breaking News On - Scan commercial claims - Page 1 : vimarsana.com

AI Tool Identifies Optimal Treatment Plans for Stroke Prevention

In a recent paper published in the journal Patterns, a team of researchers from the Ohio State University created a novel artificial intelligence model that mimics the results of randomized clinical trials to identify the courses of action that heart disease patients should take to avoid stroke.

Patients with new AS, PSA, RA Diagnosis Have High Reliance on Opioids

Patients often rely on opioids a year before and a year after a diagnosis of ankylosing spondylitis, psoriatic arthritis, or rheumatoid arthritis.

Study highlights role of health plan type in biosimilar adoption

TSH testing rates for adults without thyroid disease remain steady from 2006 to 2020

HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars

Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.

Low-Flexibility Insurance Plans More Likely to Prescribe Biosimilars

Results revealed the health plan type highly influenced the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.

Expensive Treatment Associated With Low Retention Rates Among Patients With Hepatic Encephalopathy

Investigators highlighted an association between treatment retention over time and the out-of-pocket cost for patients with hepatic encephalopathy taking rifaximin.

Interferon Tumbles, Oral Agents Gain for MS Treatment

20-year analysis demonstrates shifts in drug preference

Wildfire Smoke Exposure in Infancy Linked to Earlier First Use of Respiratory Medicine

Researchers linked wildfire smoke exposure during early developmental periods to earlier first use of upper respiratory medications.

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

A pair of studies presented at EULAR 2023 offer perspective on the potential for postpartum depression as well as symptoms of depression and anxiety during pregnancy among women with rheumatic disease.